Matches in SemOpenAlex for { <https://semopenalex.org/work/W1792540577> ?p ?o ?g. }
- W1792540577 endingPage "2664" @default.
- W1792540577 startingPage "2658" @default.
- W1792540577 abstract "Borderline tumors account for 10% to 20% of epithelial ovarian tumors, and their prognosis is outstanding; nevertheless, a mortality of up to 20% has been reported, particularly in earlier reports. There is a lack of information about the actual mortality and the rate of progression into invasive carcinoma in large and prospectively accrued populations.All women with borderline ovarian tumors undergoing primary surgery in our department or referred within 3 months from surgery performed elsewhere from 1982 to 1997 were prospectively accrued and observed.We studied 339 women (83.4% stage I, 7.9% stage II, and 8.5% stage III). The median age at diagnosis was 39 years. A total of 150 women underwent radical surgery, and 189 underwent fertility-sparing surgery. After surgery, 13 women had macroscopic residual disease. With a median follow-up of 70 months, 317 women are alive with no clinical disease (eight with documented subclinical persistence of implants), three are alive with clinical disease, two died of disease, 10 died of other reasons, and seven women have been lost to follow-up. The recurrence of disease was higher after fertility-sparing surgery (35 of 189 cases) than after radical surgery (seven of 150 cases); nevertheless, all but one woman with recurrence of borderline tumor or progression to carcinoma after conservative surgery were salvaged. We observed seven progressions (2.0%) into invasive carcinoma, five in serous tumors (2.4%), and two in mucinous tumors (1.6%). The disease-free survival is 99.6% in stage I patients, 95.8% in stage II, and 89% in stage III.The survival of patients with borderline tumors is higher than previously described in some retrospective studies. Conservative surgery is safe and may be proposed to several patients with early and disseminated disease after thorough discussion of all therapeutic options. Progression to carcinoma is approximately 2% and may be observed in both mucinous and serous tumors." @default.
- W1792540577 created "2016-06-24" @default.
- W1792540577 creator A5001346643 @default.
- W1792540577 creator A5005800844 @default.
- W1792540577 creator A5006144860 @default.
- W1792540577 creator A5052283738 @default.
- W1792540577 creator A5085199929 @default.
- W1792540577 creator A5091237695 @default.
- W1792540577 date "2001-05-15" @default.
- W1792540577 modified "2023-10-14" @default.
- W1792540577 title "Behavior of Borderline Tumors With Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective Study" @default.
- W1792540577 cites W1939059272 @default.
- W1792540577 cites W1985523627 @default.
- W1792540577 cites W1989235255 @default.
- W1792540577 cites W2001638605 @default.
- W1792540577 cites W2002866424 @default.
- W1792540577 cites W2007675369 @default.
- W1792540577 cites W2022171358 @default.
- W1792540577 cites W2024386612 @default.
- W1792540577 cites W2026302788 @default.
- W1792540577 cites W2030499882 @default.
- W1792540577 cites W2033929602 @default.
- W1792540577 cites W2053163973 @default.
- W1792540577 cites W2070599113 @default.
- W1792540577 cites W2075480569 @default.
- W1792540577 cites W2082617319 @default.
- W1792540577 cites W2086725870 @default.
- W1792540577 cites W2087654582 @default.
- W1792540577 cites W2109091278 @default.
- W1792540577 cites W2126647391 @default.
- W1792540577 cites W2150375647 @default.
- W1792540577 cites W2152605000 @default.
- W1792540577 doi "https://doi.org/10.1200/jco.2001.19.10.2658" @default.
- W1792540577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11352957" @default.
- W1792540577 hasPublicationYear "2001" @default.
- W1792540577 type Work @default.
- W1792540577 sameAs 1792540577 @default.
- W1792540577 citedByCount "356" @default.
- W1792540577 countsByYear W17925405772012 @default.
- W1792540577 countsByYear W17925405772013 @default.
- W1792540577 countsByYear W17925405772014 @default.
- W1792540577 countsByYear W17925405772015 @default.
- W1792540577 countsByYear W17925405772016 @default.
- W1792540577 countsByYear W17925405772017 @default.
- W1792540577 countsByYear W17925405772018 @default.
- W1792540577 countsByYear W17925405772019 @default.
- W1792540577 countsByYear W17925405772020 @default.
- W1792540577 countsByYear W17925405772021 @default.
- W1792540577 countsByYear W17925405772022 @default.
- W1792540577 countsByYear W17925405772023 @default.
- W1792540577 crossrefType "journal-article" @default.
- W1792540577 hasAuthorship W1792540577A5001346643 @default.
- W1792540577 hasAuthorship W1792540577A5005800844 @default.
- W1792540577 hasAuthorship W1792540577A5006144860 @default.
- W1792540577 hasAuthorship W1792540577A5052283738 @default.
- W1792540577 hasAuthorship W1792540577A5085199929 @default.
- W1792540577 hasAuthorship W1792540577A5091237695 @default.
- W1792540577 hasConcept C113280763 @default.
- W1792540577 hasConcept C121608353 @default.
- W1792540577 hasConcept C126322002 @default.
- W1792540577 hasConcept C141071460 @default.
- W1792540577 hasConcept C146357865 @default.
- W1792540577 hasConcept C150173356 @default.
- W1792540577 hasConcept C151730666 @default.
- W1792540577 hasConcept C188816634 @default.
- W1792540577 hasConcept C2776874909 @default.
- W1792540577 hasConcept C2777546739 @default.
- W1792540577 hasConcept C2779134260 @default.
- W1792540577 hasConcept C71924100 @default.
- W1792540577 hasConcept C86803240 @default.
- W1792540577 hasConceptScore W1792540577C113280763 @default.
- W1792540577 hasConceptScore W1792540577C121608353 @default.
- W1792540577 hasConceptScore W1792540577C126322002 @default.
- W1792540577 hasConceptScore W1792540577C141071460 @default.
- W1792540577 hasConceptScore W1792540577C146357865 @default.
- W1792540577 hasConceptScore W1792540577C150173356 @default.
- W1792540577 hasConceptScore W1792540577C151730666 @default.
- W1792540577 hasConceptScore W1792540577C188816634 @default.
- W1792540577 hasConceptScore W1792540577C2776874909 @default.
- W1792540577 hasConceptScore W1792540577C2777546739 @default.
- W1792540577 hasConceptScore W1792540577C2779134260 @default.
- W1792540577 hasConceptScore W1792540577C71924100 @default.
- W1792540577 hasConceptScore W1792540577C86803240 @default.
- W1792540577 hasIssue "10" @default.
- W1792540577 hasLocation W17925405771 @default.
- W1792540577 hasLocation W17925405772 @default.
- W1792540577 hasOpenAccess W1792540577 @default.
- W1792540577 hasPrimaryLocation W17925405771 @default.
- W1792540577 hasRelatedWork W2002991620 @default.
- W1792540577 hasRelatedWork W2047967234 @default.
- W1792540577 hasRelatedWork W2159396573 @default.
- W1792540577 hasRelatedWork W2347778667 @default.
- W1792540577 hasRelatedWork W2353982314 @default.
- W1792540577 hasRelatedWork W2369948003 @default.
- W1792540577 hasRelatedWork W2390427334 @default.
- W1792540577 hasRelatedWork W2415018634 @default.
- W1792540577 hasRelatedWork W2589770771 @default.
- W1792540577 hasRelatedWork W4238002189 @default.